Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,118
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,793
Class I recallsReasonable probability of serious health consequences
24,343
Class II recallsTemporary or medically reversible health consequences
2,887
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,343
Class I9,793
Class III2,887
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,343
Class I9,793
Class III2,887
Not Yet Classified1

Showing 10,241–10,260 of 20,945 recalls

FDA Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE-PGE1 17.16-0.57MG-19.45MCG/ML* INJECTABLE, 5ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Published
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

FDA Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE-PGE1 12-1MG-10MCG/ML INJECTABLE, (a) 10ml, (b) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Published
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

FDA Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE-PGE1 30-1 MG-10 MCG/ML* INJECTABLE, (a) 5ml, (b) 6ml, (c) 9ml (d) 10ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Published
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

FDA Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE 30-1 MG/ML* INJECTABLE, (a)10ml (b) 9ml, penile injection, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Published
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

FDA Recall Terminated Historical recordClass II

PGE1 40 MCG/ML* INJECTABLE, (2) 5ml (b) 10ml, (c) 6ml (d) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Published
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

FDA Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE-PGE1 22-0.8 MG-8 MCG/ML* INJECTABLE, (a) 5ml (b) 10ml, (c) 6ml, penile injection, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Published
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

FDA Recall Terminated Historical recordClass II

HYDROXYPROGESTERONE CAPROATE 250 MG/ML OIL* INJECTABLE, (a) 10ml (b) 9ml injectable, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Published
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

FDA Recall Terminated Historical recordClass II

ACETYL-L-CYSTEINE 10% P.F. OPHTH SOLUTION, 10ml, eye drops, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Published
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

FDA Recall Terminated Historical recordClass II

DEXAMETHASONE (NAPO4) 0.1% OPHTH* PRES-FREE SOLUTION, 10ml, Eye Drops, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Published
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

FDA Recall Terminated Historical recordClass II

SODIUM CHLORIDE PRES-FREE 5% OPHTH STERILE* SOLUTION. 20ml eye drops, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Published
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

FDA Recall Terminated Historical recordClass III

Clonidine HCL Injection, 1000 mcg/10mL (100 mcg/mL), 10 ML Single Dose Vial, Rx only, Manufactured for: X-Gen Pharmaceuticals, Big Flats, NY 14814, NDC 39822-2000-1.

by X-Gen Pharmaceuticals Inc.

Reason
Labeling: Label Error on Declared Strength: Side carton panel incorrectly lists the concentration as "500 mcg Clonidine Hydrochloride" rather than the correct concentration of "100 mcg Clonidine Hydrochloride" per mL.
Published
April 17, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Biotin 10 mg/mL Injection, 30 mL vial, Rx only, 511 S. Harbor Blvd., Building. F, La Habra, CA 90631, 562-352-9630.

by Auro Pharmacies Inc. DBA Central Drugs

Reason
Failed pH Specification: product does not meet pH label claim.
Published
April 17, 2019
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

Theo Chocolate Inc

Product
Sea Salt 70% Dark Chocolate 3 oz. bars, wrapped in foil and…
Reason
Theo Chocolate Sea Salt 70% Dark Chocolate Bar is recalled due to undeclared milk.
Published
April 17, 2019
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

GOOD KARMA FOODS INC

Product
PL Trader Joe Natural Creamer - Vanilla 12/32oz, Plastic bot…
Reason
Product was recalled due to undeclared milk. The Contains statement does not list milk as an ingredient.
Published
April 17, 2019
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass III

Merical, LLC

Product
Walgreens Probiotic 12.5 Billion Active Cultures, 30 capsule…
Reason
Incorrect probiotic strain used in formulation which did not match product labeling.
Published
April 17, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

NORepinephrine 4 mg added to 5% Dextrose 250 mL Bag (PF), 4 mg / 250 mL, 250 mL IV bag, Rx only, KRS Global Biotechnology: 791 Park of Commerce Blvd., Boca Raton, FL 33487. NDC 3321674481

by KRS Global Biotechnology, Inc

Reason
Labeling: Label mix-up
Published
April 10, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

NORepinephrine 16 mg added to 0.9% Sodium Chloride (PF), 16 mg / 250 mL, 250 mL IV bag, Rx only, KRS Global Biotechnology: 791 Park of Commerce Blvd., Boca Raton, FL 33487. NDC 3321678343

by KRS Global Biotechnology, Inc

Reason
Labeling: Label mix-up
Published
April 10, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Morphine Sulfate USP Milled, Active Pharmaceutical Ingredient, Rx only, Johnson Matthey Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, NJ 08066-1742

by Johnson Matthey Inc.

Reason
Microbial Contamination of Non-Sterile Products: Bioburden out of specification results for Morphine Sulfate API.
Published
April 10, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.

by Jubilant Cadista Pharmaceuticals, Inc.

Reason
Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.
Published
April 10, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Clindamycin Injection, USP, 900 mg/6 mL (150 mg/mL), 6 mL vial, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA. NDC 47781-621-94

by Pfizer Inc.

Reason
Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point
Published
April 10, 2019
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.